| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.40B | 37.75B | 36.57B | 34.08B | 31.68B | 29.04B |
| Gross Profit | 15.45B | 15.80B | 16.96B | 34.08B | 31.68B | 14.97B |
| EBITDA | -15.52B | 11.30B | 12.01B | 14.45B | 12.35B | 9.98B |
| Net Income | 3.94B | 3.89B | 6.30B | 6.38B | 5.90B | 5.03B |
Balance Sheet | ||||||
| Total Assets | 363.80B | 360.39B | 351.48B | 346.99B | 335.88B | 299.93B |
| Cash, Cash Equivalents and Short-Term Investments | 21.30B | 34.20B | 22.07B | 19.67B | 19.63B | 15.15B |
| Total Debt | 266.30B | 265.91B | 256.62B | 251.83B | 230.81B | 206.04B |
| Total Liabilities | 304.32B | 302.91B | 293.91B | 294.55B | 282.83B | 254.66B |
| Stockholders Equity | 51.00B | 48.99B | 51.67B | 48.33B | 49.04B | 42.60B |
Cash Flow | ||||||
| Free Cash Flow | 3.10B | 1.55B | 1.17B | -11.64B | -25.33B | -31.64B |
| Operating Cash Flow | 9.15B | 9.97B | 3.73B | -7.69B | -14.87B | -24.46B |
| Investing Cash Flow | -1.92B | -3.54B | -2.40B | -1.77B | -9.85B | -10.55B |
| Financing Cash Flow | -11.99B | -5.60B | 1.59B | 9.61B | 28.52B | 42.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$680.00M | 6.20 | 8.46% | 5.46% | -24.04% | 60.24% | |
74 Outperform | HK$20.99B | 3.87 | 13.09% | 5.84% | 3.17% | 23.13% | |
69 Neutral | HK$6.51B | 4.35 | 7.87% | 11.28% | 0.59% | -5.95% | |
68 Neutral | HK$1.39B | 3.83 | 9.89% | 7.51% | 1.11% | 3.98% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$38.19B | 8.16 | 7.90% | 6.70% | -1.77% | -24.74% | |
59 Neutral | HK$312.82M | 22.50 | 0.49% | ― | 8.77% | -76.88% |
Far East Horizon Limited announced a drawdown of HKD350,000,000 under its US$4 billion Medium Term Note and Perpetual Securities Programme. The proceeds from this issuance, rated BBB- by S&P, will be used for working capital and general corporate purposes, with potential on-lending to its subsidiaries in the PRC, pending necessary approvals.
Far East Horizon Limited announced a drawdown of JPY8,000,000,000 under its Medium Term Note and Perpetual Securities Programme. The proceeds from this issuance, which is aimed at professional investors, will be used to finance and refinance green and social projects, aligning with the company’s sustainable financing framework.
Far East Horizon Limited reported a year-on-year increase in profit attributable to ordinary shareholders for the first three quarters of 2025, driven by steady growth in its financial business. The company maintained robust asset quality and saw significant expansion in its inclusive finance segment, with interest-earning assets increasing by over 60% year-on-year. Despite a decline in revenue for Horizon Healthcare, the group remained profitable overall. The company’s effective risk management strategies ensured a stable liquidity position, and it continues to focus on its ‘finance + industry’ development strategy to enhance shareholder returns.
Far East Horizon Limited announced an adjustment to the conversion price of its U.S.$250,000,000 zero coupon guaranteed convertible bonds due 2026, as a result of declaring an interim dividend. The conversion price adjustment, effective from 24 September 2025, will lower the price from HK$6.70 to HK$6.48 per share, increasing the maximum number of shares issuable upon full conversion. This adjustment reflects the company’s strategic financial management and could impact shareholder value and market perception.